ALCIDION GROUP LTD

Alcidion Group (ALC.AX) drops 1% to AUD 0.10, trading 73k shares, while its clinical decision‑support tech stays focused on improving patient care in the US and Australia.

Alcidion Group Ltd. (ALC.AX) sees modest gains as a niche health‑tech firm, offering clinical decision‑support solutions; investors weigh 52‑week highs, low trading volume, and partnership potential.

Alcidion stock climbs 1.05% amid a stable 52‑week range – a key update on its health‑tech solutions and market outlook.